Jim Simons Deciphera Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.58 - $17.36 $1.26 Million - $1.61 Million	92,900 Added 21.24%	530,200 $8.34 Million
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $1.27 Million - $2.08 Million	125,900 Added 40.43%	437,300 $7.05 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $2.38 Million - $2.95 Million	190,800 Added 158.21%	311,400 $3.96 Million
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $1.47 Million - $1.77 Million	-110,718 Reduced 47.86%	120,600 $1.7 Million
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $2.01 Million - $3.11 Million	140,618 Added 155.04%	231,318 $3.57 Million
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $1.35 Million - $1.73 Million	90,700 New	90,700 $1.49 Million
Q2 2022 Aug 12, 2022	BUY	$9.11 - $13.98 $809,879 - $1.24 Million	88,900 New	88,900 $1.17 Million
Q4 2021 Feb 11, 2022	SELL	$7.7 - $37.13 $267,960 - $1.29 Million	-34,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $920,808 - $1.29 Million	34,800 New	34,800 $1.18 Million
Q2 2020 Aug 13, 2020	SELL	$37.05 - $65.03 $15.5 Million - $27.2 Million	-418,600 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $6.86 Million - $14.2 Million	204,000 Added 95.06%	418,600 $17.2 Million
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $2.25 Million - $4.96 Million	70,900 Added 49.34%	214,600 $13.4 Million
Q3 2019 Nov 13, 2019	BUY	$19.95 - $38.85 $2.87 Million - $5.58 Million	143,700 New	143,700 $4.88 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.